NCT01764178.

Methods	Randomised, open‐label, cross‐over trial
Participants	Healthy male volunteers Age 20‐55 years at the time of screening BMI 19‐26 kg/m2 at the time of screening
Interventions	Livalo fixed combination drug (pitavastatin + valsartan) Comparator: pitavastatin, valsartan
Outcomes	Primary outcomes: Cmax and AUC of study drugs after single oral administration Secondary outcomes: AUCinf of study drugs after single oral administration t1/2β of study drugs after single oral administration Tmax of study drugs after single oral administration
Notes